Sigma Healthcare Ltd
SIG
Company Profile
Business description
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
Contact
2125 Dandenong Road
Level 6
Clayton
MelbourneVIC3168
AUST: +61 392159215
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 January 2025
Employees
156
Sigma Healthcare Ltd News & Analysis
stocks
The surge in price of ASX listed share price is unwarranted
Good news as a proposed merger is approved but investors may be too optimistic.
personal-finance
A long-awaited dip into personal finance: Sim’s monthly insights
Morningstar’s new Investment Associate looks back on her first month of stories.
stocks
The ASX healthcare player soaring to all-time highs
The steep market reaction comes after a recent announcement by the ACCC.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,567.00 | 12.10 | -0.14% |
| CAC 40 | 7,194.03 | 4.42 | -0.06% |
| DAX 40 | 19,085.43 | 80.65 | 0.42% |
| Dow JONES (US) | 43,408.47 | 139.53 | 0.32% |
| FTSE 100 | 8,121.17 | 36.10 | 0.45% |
| HKSE | 19,601.11 | 103.90 | -0.53% |
| NASDAQ | 18,966.14 | 21.33 | -0.11% |
| Nikkei 225 | 38,026.17 | 326.17 | -0.85% |
| NZX 50 Index | 12,765.24 | 28.18 | 0.22% |
| S&P 500 | 5,917.11 | 0.13 | 0.00% |
| S&P/ASX 200 | 8,323.00 | 3.30 | -0.04% |
| SSE Composite Index | 3,370.40 | 2.41 | 0.07% |